Home > Cashflow Statement > GENPHARMASEC

GENPHARMASEC
Cashflow Statement

GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023
Profit Before Tax₹1.88 Cr₹0.25 Cr₹0.28 Cr
Adjustment ₹-1.04 Cr₹0.39 Cr₹0.16 Cr
Changes In working Capital ₹2.22 Cr₹-3.54 Cr₹-3.77 Cr
Cash Flow after changes in Working Capital ₹3.06 Cr₹-2.90 Cr₹-3.32 Cr
Cash Flow from Operating Activities ₹2.99 Cr₹-2.95 Cr₹-3.06 Cr
Cash Flow from Investing Activities ₹-15 Cr₹-28 Cr₹0.36 Cr
Cash Flow from Financing Activities ₹-1.25 Cr₹48 Cr₹3.08 Cr
Net Cash Inflow / Outflow ₹-14 Cr₹17 Cr₹0.39 Cr
Opening Cash & Cash Equivalents ₹19 Cr₹1.99 Cr₹1.61 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---
Cash & Cash Equivalent of Subsidiaries under liquidations ---
Translation adjustment on reserves / op cash balalces frgn subsidiaries ---
Effect of Foreign Exchange Fluctuations ---
Closing Cash & Cash Equivalent ₹5.27 Cr₹19 Cr₹1.99 Cr

Compare Cashflow Statement of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹67.6 Cr 36.9% 0.9% -44.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,064.1 Cr -0.3% -11.5% -21.4% Stock Analytics
KIRI INDUSTRIES ₹2,270.1 Cr 7.6% -13.3% -40.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,623.2 Cr 15.1% 0.2% -25.2% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,083.0 Cr 5.2% 5.8% 20.2% Stock Analytics
BODAL CHEMICALS ₹810.0 Cr 5.7% 29.9% -7.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

36.9%

0.9%

-44.3%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses